CING
NASDAQ · Pharmaceuticals
Cingulate Inc
$5.02
+0.08 (+1.62%)
Open$4.94
Previous Close$4.94
Day High$5.11
Day Low$4.92
52W High$11.89
52W Low$3.16
Volume—
Avg Volume137.7K
Market Cap71.92M
P/E Ratio—
EPS$-4.33
SectorPharmaceuticals
Analyst Ratings
Strong Buy
9 analysts
Price Target
+186.5% upside
Current
$5.02
$5.02
Target
$14.38
$14.38
$9.95
$14.38 avg
$17.66
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 8.37M | 8.17M | 9.32M |
| Net Income | 2.92M | 2.10M | 3.15M |
| Profit Margin | 34.9% | 25.8% | 33.8% |
| EBITDA | 4.25M | 3.98M | 4.18M |
| Free Cash Flow | 2.06M | 2.44M | 3.61M |
| Rev Growth | +14.6% | -6.6% | +11.6% |
| Debt/Equity | 0.37 | 0.32 | 0.41 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |